The Vanson Bourne survey found that 44% of healthcare leaders are piloting or conducting proof-of-concept projects for agentic AI, and 21% plan to implement it within the next year.

Overview Debates Related claims Topics Sources

On October 20, 2026, AstraZeneca announced a collaboration with Oracle to leverage artificial intelligence, cloud, and healthcare data capabilities to refine clinical research

AstraZeneca and Oracle plan to combine drug development expertise with artificial intelligence and healthcare data to identify eligible patients for clinical trials and monitor safety signals

Epic Systems chief security officer Stirling Martin participated in Anthropic's Project Glasswing program to test how attackers could utilize open-source artificial intelligence agents to access confidential health records.

US regulatory guidance OCC Bulletin 2026-13, issued jointly by the OCC, Federal Reserve Board, and FDIC on April 17, 2026, explicitly excluded generative and agentic AI models from its scope.

The American Medical Association's framework focuses on four questions covering clinical functions, evidence of performance, conditions of permission, and risk accountability.

The Financial Stability Board declined to framing AI systems as synthetic employees, citing concerns that the analogy obscures unpredictable autonomous decisions.

The American Medical Association released a new governance framework on October 15, 2026, to guide the safe deployment of agentic AI assuming clinical functions in healthcare.

In a survey of 250 U.S. healthcare leaders, 28% reported deploying agentic AI tools and 72% reported that agentic AI is occasionally implemented without IT approval.

Moody's warned in August 2026 that technology providers OpenAI and Anthropic face investor pressure to reach profitability, creating potential pricing leverage over dependent financial institutions.

In a survey of 250 U.S. healthcare leaders, 44% of respondents reported conducting pilots or proof-of-concept projects with agentic AI tools.

Suki plans to use its Series E funding to develop autonomous AI agents to manage post-visit healthcare tasks including referrals, prior authorizations for new medications, filling orders, and scheduling follow-ups.

The acquisition of Proscia is intended to offer AI-enabled synergies with Agilent Technologies' companion diagnostics business in drug discovery and clinical research.

Suki's planned AI agents will utilize clinical information gathered from the company's existing documentation and point-of-care tools to execute post-visit healthcare tasks.

Suki plans to use its Series E funding to deepen integration with its more than 30 existing health technology partners, including Optum, Zoom, and athenahealth, by embedding new AI agent capabilities.

The Upper Merion expansion forms part of a broader $1.2 billion investment by GSK earmarked for advanced manufacturing, artificial intelligence, and digital technologies.

Building AI-native hospitals from scratch is more effective than retrofitting legacy health systems

The University of Texas at Austin is designing an academic medical center built around artificial intelligence prior to beginning construction.

Dell Medical School dean Dr. Claudia Lucchinetti described the tentacle problem as tacking new artificial intelligence tools and workflows onto broken legacy IT systems built decades earlier.

Codametrix and Solventum stated they have integrated strict coding compliance guidelines and guardrails into their artificial intelligence systems to prevent inaccurate or fraudulent coding.

PwC analysts attribute a projected 9% increase in health insurers' medical costs for 2027 to the adoption of artificial intelligence-backed billing tools.